Dr. Rahul Singh

Assistant Professor
Teaching, Research methodology & Pharmacology


Professional Biography

Rahul Singh is an expert in the area of drug discovery and pharmacology with a background in cancer biology, immunology and enzyme pharmacology especially in the areas of tumor cell biology and stem cell research with specific training and expertise in the key research areas of In vitro and In vivo systems. He has more than 17 years of Research and Development and academic experience in leading pharmaceutical industries and institutes like Ranbaxy Research Laboratories Gurgaon, All India Institute of Medical Sciences, New Delhi AIIMS, German Cancer Research Centre, Heidelberg (Germany), GVK Bio Hyderabad and G D Goenka University in the area of drug discovery and cancer biology.

Prior to taking up the current role in 2018, Rahul Singh served in corporate position such as a Scientific Manager (Pharmacology), GVK Bio and as a Scientist (Pharmacology) at Ranbaxy Research Laboratories Gurgaon.

Rahul Singh holds a PhD from Department of Experimental Surgery, University of Heidelberg (Germany); ME (Biotechnology) from Birla Institute of Technology and Science BITS, Pilani; and B. Pharmacyfrom Indian Institute of Technology - Banaras Hindu University.

Publications (from 2015)

Scholarly Journals
‘The contribution of hematopoietic stem/progenitor cell and bone marrow stroma cell Cd44v6 and Cd44v7 to hematopoiesis’, Journal of Stem Cell Research and Therapy. 5(7), pp. 295-310. (Singh, R., Thirupathi, P., and Zoeller, M., 2015).

Scholarly Conference Proceedings
‘The importance of CD44 as a tumor biomarker and drug target in cancer therapy’, Second International Conference on Fostering Interdisciplinary Research in Health Sciences ICFIRHS 2019, AIMST University Malaysia. (Singh,R., and Dutt, R.,2019).

Current Research

Rahul Singh's current research interests are focused to understand the disease and bring an effective and safe treatment to the patients, and to develop the skill set and knowledge in the area of development of novel therapies to target leukemia stem cells. Also, to explore tumor biomarker and drug target for the cancer therapy is his keen interest.

Consultancies (from 2015)

2015-2017
Department of Biology, Intonation Research Laboratories Hyderabad, Industry, Science and Research (India) Research and Business development Mentoring and Training (Rahul Singh).

Contribution to the Profession and Awards (from 2015)

Editorial Review Board, International Journal of Biomedical Science and Engineering {Publisher –Science Publishing Group].

Member, European Federation of Biotechnology (EFB) c/o DECHEMA e.V., Theodor - Heuss-Allee 25 60486 Frankfurt, Germany.

Best Oral Paper entitled ‘The importance of CD44 as a tumor biomarker and drug target in cancer therapy’, Second International Conference on Fostering Interdisciplinary Research in Health Sciences- ICFIRHS 2019, AIMST University Malaysia.

Successfully completed a course of “Writing in the Sciences” from Stanford University, November 2015.

Associate Member of the Australia & New Zealand Musculoskeletal Clinical Trials Network (ANZMUSC Clinical Trial Network).